(Q44082858)

29 November 2017

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light (English)

1 reference

29 November 2017

ultraviolet radiation

0 references

5

Kristen A Bernard

1 reference

29 November 2017

3

Harvey J Alter

1 reference

29 November 2017

Lily Lin

1

1 reference

29 November 2017

Carl V Hanson

2

1 reference

29 November 2017

Valérie Jauvin

4

1 reference

29 November 2017

Krishna K Murthy

6

1 reference

29 November 2017

Peyton Metzel

7

1 reference

29 November 2017

Laurence Corash

8

1 reference

29 November 2017

1 April 2005

1 reference

29 November 2017

1 reference

29 November 2017

45

1 reference

29 November 2017

4

1 reference

29 November 2017

580-590

1 reference

Hepatitis B Virus Infection in Chimpanzees: Titration of Subtypes

29 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2005.04316.X

Non-A, non-B hepatitis in chimpanzees and marmosets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2005.04316.X

Coronaviridae and SARS-associated coronavirus strain HSR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2005.04316.X

Chronic wasting disease and potential transmission to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0041-1132.2005.04316.X

Identification of HTLV-I- or HTLV-II-producing cells by cocultivation with BHK-21 cells stably transfected with a LTR-lacZ gene construct

21 January 2018

1 reference

12 December 2020

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

1 reference

12 December 2020

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

1 reference

12 December 2020

Replication of HIV-1 in primary monocyte cultures

1 reference

12 December 2020

Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR

1 reference

12 December 2020

Virus Inactivated Single-Donor Fresh Plasma Preparations

1 reference

12 December 2020

Inactivation of cytomegalovirus in platelet concentrates using Helinx technology

1 reference

12 December 2020

FDA approach to evaluation of pathogen reduction technology

1 reference

12 December 2020

Infectious cDNA clone of the epidemic west nile virus from New York City

1 reference

12 December 2020

Boosting the sensitivity of real-time polymerase-chain-reaction testing for SARS.

1 reference

12 December 2020

Isolation and transmission of human retrovirus (human t-cell leukemia virus).

1 reference

12 December 2020

Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA

1 reference

12 December 2020

Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization

1 reference

12 December 2020

Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles

1 reference

12 December 2020

Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: a model of surrogate human hepatitis B virus infectivity

1 reference

12 December 2020

Parvovirus B19 transmission by heat-treated clotting factor concentrates

1 reference

12 December 2020

Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus

1 reference

12 December 2020

EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines

1 reference

12 December 2020

Occult hepatitis B virus infection: implications in transfusion

1 reference

12 December 2020

Inactivation of the human immunodeficiency viruses (HIV-1 and HIV-2) during the manufacturing of placental albumin and gammaglobulins

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Inactivation of parvovirus B19 during pasteurization of human serum albumin.

1 reference

12 December 2020

Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.

1 reference

12 December 2020

Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors

1 reference

12 December 2020

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

1 reference

12 December 2020

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma

1 reference

12 December 2020

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

12 December 2020

Removal of small non-enveloped viruses by nanofiltration

1 reference

12 December 2020

The molecular biology of the hepatitis B viruses

1 reference

12 December 2020

Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.

1 reference

12 December 2020

Different susceptibility of B19 virus and mice minute virus to low pH treatment

1 reference

12 December 2020

Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor

1 reference

12 December 2020

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002

1 reference

12 December 2020

Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

1 reference

12 December 2020

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity

1 reference

12 December 2020

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

1 reference

12 December 2020

Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

1 reference

12 December 2020

Eliminating Trachoma in Areas with Limited Disease

1 reference

12 December 2020

Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers

1 reference

12 December 2020

West Nile virus infection transmitted by blood transfusion

1 reference

12 December 2020

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

1 reference

12 December 2020

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

12 December 2020

Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma

1 reference

12 December 2020

The future use of pathogen-inactivated platelet concentrates

1 reference

12 December 2020

Transfusion medicine. First of two parts--blood transfusion

1 reference

12 December 2020

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

1 reference

12 December 2020

10.1111/J.0041-1132.2005.04316.X

Identifiers

DOI

1 reference

29 November 2017

0 references

1 reference